- ￥1090 - 1590
- CUSABIO
- 武汉
- CSB-PA050138
- 2025年07月05日
- ELISA, WB
- Rabbit
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Synthesized peptide derived from Human BRCA1 around the non-phosphorylation site of S1457.
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
-20°C
- 克隆性：
多克隆
- 标记物：
Non-conjugated
- 适应物种：
Human
- 保质期：
12个月
- 抗原来源：
Human
- 目录编号：
CSB-PA050138
- 级别：
多克隆抗体
- 库存：
充足
- 供应商：
武汉益普生物科技有限公司
- 宿主：
Rabbit
- 应用范围：
ELISA, WB
- 靶点：
BRCA1
- 抗体英文名：
BRCA1 Antibody
- 规格：
50μg/100μg
| 规格： | 50μg | 产品价格： | ￥1090.0 |
|---|---|---|---|
| 规格： | 100μg | 产品价格： | ￥1590.0 |
| 产品名称 | BRCA1 Antibody |
| 货号 | CSB-PA050138 |
| 别名 | BRCA 1 antibody; BRCA1 antibody; BRCA1 DNA repair associated antibody; BRCA1/BRCA2 containing complex subunit 1 antibody; BRCA1/BRCA2-containing complex; subunit 1 antibody; BRCA1_HUMAN antibody; BRCAI antibody; BRCC 1 antibody; BRCC1 antibody; Breast and ovarian cancer susceptibility protein 1 antibody; Breast Cancer 1 antibody; Breast Cancer 1 Early Onset antibody; Breast cancer type 1 susceptibility protein antibody; BROVCA1 antibody; FANCS antibody; IRIS antibody; PNCA4 antibody; PPP1R53 antibody; Protein phosphatase 1 regulatory subunit 53 antibody; PSCP antibody; RING finger protein 53 antibody; RNF53 antibody |
| 抗体类型 | Polyclonal Antibody |
| 克隆类型 | Polyclonal |
| Uniprot No. | P38398 |
| 基因名 | BRCA1 |
| 免疫原种属 | Human |
| 免疫原 | Synthesized peptide derived from Human BRCA1 around the non-phosphorylation site of S1457. |
| 宿主 | Rabbit |
| 反应种属 | Human |
| 应用范围 | ELISA, WB |
| 抗体亚型 | IgG |
| 标记方式 | Non-conjugated |
| 产品提供形式 | Liquid |
| 纯化方式 | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| 研究领域 | Epigenetics and Nuclear Signaling |
| 保存缓冲液 | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| 储存条件 | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Development of a Scoring System to Screen for BRCA1/2 Mutations
Selection for genetic testing for pathogenic mutations in BRCA1 and BRCA2 is an important area of healthcare. While testing costs for mutational analysis are falling, costs of tests in North America remain in excess of $3,000. Most countries
Developing Functional Assays for BRCA1 Unclassified Variants
Women with a family history of breast cancer have mutations in one of the breast cancer susceptibility genes, BRCA1 or BRCA2 . Since the discovery of these two genes, around 100,000 women worldwide have undergone genetic testing
Ovarian Cancer Gene Therapy with BRCA1An Overview
The human breast and ovarian cancer susceptibility gene BRCA1 is a tumorsuppressor gene which is mutated and lost in hereditary breast and ovarian cancer, and has both alleles mutated in approximately 10-15% of cases of sporadic ovarian cancer
技术资料暂无技术资料 索取技术资料
